This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Universitéde Montreal, British Columbia Cancer Agency Branch, Fred Hutchinson Cancer Center. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montréal, CA (2019)
- Montreal, CA (2023 - 2024)
Company Filing History:
3 out of 189 
1 out of 66 
1 out of 309 
Years Active: 2019-2024
Title: Jalila Chagraoui: Innovator in Immunology
Introduction
Jalila Chagraoui is a prominent inventor based in Montréal, Canada. She has made significant contributions to the field of immunology, particularly in the expansion of immune cells for therapeutic applications. With a total of 3 patents, her work focuses on enhancing immune responses to improve patient outcomes.
Latest Patents
One of her latest patents is titled "Expansion of NK and DC cells in vivo mediating immune response." This patent describes a method for expanding dendritic (DC) cells and natural killer (NK) cells in vivo within a patient. The process involves producing a graft of stem and progenitor cells cultured with UM171 or its analogues, which are then expanded before administration to the patient. This method aims to increase the population of DC and NK cells, thereby enhancing the immune response and reducing transplant-related mortality, severe graft-versus-host disease, relapse, and severe viral infections.
Another notable patent is "Selection of human hematopoietic stem cells using EPCR." This invention provides a method for expanding ex vivo hematopoietic stem cells (HSC). The method includes selecting a population of Endothelial Protein C Receptor (EPCR) HSC, culturing the selected cells to expand the EPCR HSC, and utilizing the expanded cells for stem cell transplantation.
Career Highlights
Jalila Chagraoui has worked with esteemed institutions such as Université de Montréal and the British Columbia Cancer Agency Branch. Her research has significantly advanced the understanding of immune cell expansion and its applications in clinical settings.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Guy Sauvageau and Iman Fares. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Jalila Chagraoui's work in immunology exemplifies the impact of innovative research on patient care. Her patents reflect her commitment to advancing medical science and improving therapeutic strategies for immune-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile